Tip:
Highlight text to annotate it
X
>>> DR. JAY K. HARNESS: I want to share with you a recent report that was presented at
the San Antonio Breast Cancer Symposium.
The International Breast Cancer Study Group released data on a 57-month follow up study
on the role of axillary dissection in clinically negative breast cancer patients.
Now in this study, what was being compared was: one group had axillary dissection, who
were clinically negative, versus another group who did not have axillary dissection, who
again upfront were clinically negative. Also included in the study were sentinel lymph
node patients who had just micro metastases within their lymph nodes.
In other words, this prospective way looked at the results of tracking these patients
over 57 months, with those that did and did not have axillary dissection. And so what’s
the bottom line of the study?
At 57 months, there was really no difference between the two groups. This report is almost
identical to the report earlier in 2011 on this very same subject that came from here
in the United States.
The important factor in both of these studies is that women do need to receive the normal
adjunctive therapies. So radiation therapy, anti-hormonal therapy, chemotherapy, what
we normally do, needs to be done in order to have these similarities between the two
groups.
So here is what you need to know: Women with early stage breast cancer, whose axillary
regions are clinically negative, do not have to undergo axillary lymph node dissection
in order to improve their survival or to have improved local control of their cancer in
the axillary region.
Please discuss this issue with the team that is taking care of you. This is an important
piece of news that again affirms this very subject that was released earlier in 2011.
Hi, I am Dr. Jay Harness and I want to share with you important information that I believe
that every newly diagnosed patient with breast cancer needs to know.
Susan Denver: I am a breast cancer survivor.
Katherine Stockton: I am a breast cancer survivor.
Coree: I am a breast cancer survivor.
Susan Denver: And I want every woman to know…
Katherine Stockton: …about personalized breast cancer treatment…
Susan Denver: …and the genomic test.
Coree: A test that helps guide a woman and her doctor…
Katherine Stockton: …to the best treatment options for her.
Susan Denver: Pass it on!